Cagrilintide
Cagrilintide (CagriSema)
A long-acting amylin analog being studied in combination with semaglutide (CagriSema). Early results suggest enhanced weight loss beyond semaglutide alone.
Key Research
Peer-Reviewed Evidence • 3 Citations
Cagrilintide plus semaglutide 2.4mg for weight management (REDEFINE 1)
Frias JP et al.•N Engl J Med•2024•PMID: 38587236
Key Finding: CagriSema combination achieved ~25% body weight loss, significantly exceeding either component alone in phase III trials.
View on PubMedLong-acting amylin analogue cagrilintide shows potent anti-obesity effects in preclinical studies
Lau DCW et al.•Diabetes Obes Metab•2021•PMID: 33942490
Key Finding: Cagrilintide as a long-acting amylin analog reduces food intake through central satiety mechanisms distinct from GLP-1 pathways.
View on PubMedThe amylin pathway as a therapeutic target for metabolic disease
Lutz TA•Annu Rev Physiol•2022•PMID: 34654276
Key Finding: Amylin analogs like cagrilintide complement GLP-1 action by enhancing satiety signals, representing a novel dual-pathway approach to obesity.
View on PubMedCitations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.
📊 Evidence by Outcome
Phase 2 data shows added weight loss when combined with semaglutide. Not yet available as monotherapy.
4 studies • Consistency: Moderate • Effect: Moderate
👥 Community Insights
Interesting data but not widely available yet. Waiting for CagriSema approval.
Community member • Europe• Verified
📋 Protocol Snapshot
Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.
Related Treatments
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, community data, and other factors — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.